Abstract Endometrial cancer accounts for~ 76,000 deaths among women each year
worldwide. Disease mortality and the increasing number of new diagnoses make …

Background and objective Predicting response to therapy for each patient's tumor is critical
to improving long-term outcomes for muscle-invasive bladder cancer. This study aims to …

Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine carcinoma
without a known dysplastic precursor. In some cases, MCC is associated with SCCIS in the …

Clinicopathological evidence supports endometrial atypical hyperplasia (AH) or endometrial
intraepithelial neoplasia as the precursor of uterine endometrioid carcinoma (EC), the most …

Although squamous cell carcinomas (SCC) are the most frequent human solid tumor at
many anatomic sites, the driving molecular alterations underlying their progression from …

Localized prostate cancer is frequently composed of multiple spatially distinct tumors with
significant inter-and intra-tumoral molecular heterogeneity. This genomic diversity gives rise …

Purpose: The potential biological determinants of aggressive prostate cancer in African
American (AA) men are unknown. Here we characterize prostate cancer genomic alterations …

Low-grade, low-stage endometrioid carcinomas (LGLS EC) demonstrate 5-yr survival rates
up to 95%. However, a small subset of these tumors recur, and little is known about …

Background Endometrial cancer (EC) is a major gynecological cancer with increasing
incidence. It comprises four molecular subtypes with differing etiology, prognoses, and …

Squamoid eccrine ductal carcinoma is a rare infiltrative tumor with morphologic features
intermediate between squamous cell carcinoma (SCC) and sweat gland carcinomas such …